Dual Hsp110 and sGC regulators counteract pulmonary arterial hypertension
Aug. 29, 2024
Pulmonary arterial hypertension (PAH) is a progressive disorder where high pulmonary artery pressure and vascular resistance lead to progressive dyspnea, and right ventricular hypertrophy (RVH).